Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

newsbytesapp.com - Dwaipayan Roy - Why Indian pharma industry is relieved after US-Iran deal
Why Indian pharma industry is relieved after US-Iran deal
NewsBytes

The ongoing war had severely disrupted maritime transit through the Strait of Hormuz, affecting the supply of key petrochemical inputs. The blockade caused a major shortage of propylene, an essential feedstock for producing pharmaceutical-grade…

fool.com - Cory Renauer - Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
The Motley Fool

Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN +0.75%), reported the sale of 5,222 ordinary shares for a total of approximately $143,000, as disclosed in a SEC Form 4 filing. MetricValueShares sold (direct)5,222Transaction…

thehindubusinessline.com - These 8 pharma and healthcare stocks may be in focus on Monday
These 8 pharma and healthcare stocks may be in focus on Monday
BusinessLine

Dr. Reddy's Laboratories Ltd, along with its subsidiaries, has announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif, in the US, expanding its oncology portfolio and reinforcing its commitment to improving…

cityam.com - Felix Armstrong - Australian pharma giant Sigma quits Boots takeover talks
Australian pharma giant Sigma quits Boots takeover talks
City AM

Australian pharmacy giant Sigma has walked away from talks over a £7.5bn private takeover of Boots, renewing hopes that the high street pharmacy could float in London. The Australian firm said on Monday that a deal with Boots would not meet…

marketbeat.com - Royalty Pharma PLC $RPRX Shares Bought by Entropy Technologies LP
Royalty Pharma PLC $RPRX Shares Bought by Entropy Technologies LP
MarketBeat

Entropy Technologies LP boosted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 171.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 88,652 shares of the biopharmaceutical…

marketbeat.com - BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of 'Moderate Buy' by Analysts
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of 'Moderate Buy' by Analysts
MarketBeat

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the twenty-six research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell…

rediff.com - Rediff News - Stock markets surge 1,172 pts as US-Iran reach peace deal
Stock markets surge 1,172 pts as US-Iran reach peace deal
Rediff.com

Stock market benchmark indices Sensex and Nifty surged in early trade on Monday, mirroring a rally in global equities and a sharp decline in crude oil prices, after the US and Iran finalised a deal to end their 107-day war. The 30-share BSE Sensex…

rediff.com - Nandita Malik - Indian Stock Market Rallies: Sensex, Nifty Jump on US-Iran Peace Deal & Crude Oil Price Decline
Indian Stock Market Rallies: Sensex, Nifty Jump on US-Iran Peace Deal & Crude Oil Price Decline
Rediff.com

Indian stock markets, including the Sensex and Nifty, experienced a significant surge following a global rally and a sharp decline in crude oil prices, as the US and Iran finalised a peace deal to end their conflict and reopen the Strait of Hormuz.

thehindubusinessline.com - Nifty Prediction Today - June 15, 2026: Nifty futures: Surpasses a barrier
Nifty Prediction Today - June 15, 2026: Nifty futures: Surpasses a barrier
BusinessLine

Nifty 50 opened with a considerable gap-up at 23,985 today versus last week's close of 23,623. The index is now hovering around 23,950, up about 1.4 per cent. The advance/decline ratio of the index is now 46/4, showing a strong positive bias.

yahoo.com - Ramish Cheema - Jim Cramer Explains Johnson & Johnson's (JNJ) Shares Have Gained
Jim Cramer Explains Johnson & Johnson's (JNJ) Shares Have Gained
Yahoo!

Jim Cramer Didn't Hold Back On SpaceX's IPO & Discussed These 12 Stocks. Johnson & Johnson (NYSE:JNJ) is one of the stocks discussed by Jim Cramer. Johnson & Johnson (NYSE:JNJ)'s shares are up by 53% over the past year and by 15% year-to-date.

globenewswire.com - HMNC Holding GmbH - HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE
HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE
GlobeNewswire

Financing will accelerate the development of HMNC's neurosciences portfolio, including Phase 3-readiness activities for Ketabon (KET01) and Nelivabon (BH-200) Agreement grants MEDICE exclusive European commercialization rights for KET01, with…

thehindu.com - Pti - Stock markets surge tracking global rally, drop in oil prices as U.S., Iran reach peace deal
Stock markets surge tracking global rally, drop in oil prices as U.S., Iran reach peace deal
The Hindu

Stock market benchmark indices Sensex and Nifty surged in early trade on Monday (June 15, 2026), mirroring a rally in global equities and a sharp decline in crude oil prices, after the U.S. and Iran finalised a deal to end their 107-day war. The…

thehindubusinessline.com - Team BL - Stock Market Highlights June 15: Sensex surges 736 points, Nifty nears 24,000 as Iran-US peace deal lifts market sentiment
Stock Market Highlights June 15: Sensex surges 736 points, Nifty nears 24,000 as Iran-US peace deal lifts market sentiment
BusinessLine

Sensex Today, Nifty 50 | Stock Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 15th June 2026. Indian stock market extended sharp gains on Monday with both benchmark…

thehindubusinessline.com - Sensex gains 736 points, Nifty closes above 23,850 as US-Iran deal drives crude prices lower
Sensex gains 736 points, Nifty closes above 23,850 as US-Iran deal drives crude prices lower
BusinessLine

Benchmark equity indices ended higher for the second consecutive session on Monday, although they pared some gains in the latter half of the session amid profit booking. Investor sentiment remained upbeat after reports of an interim US-Iran peace…

fool.com - Keith Speights - 3 High-Yield Dividend Stocks to Buy Hand Over Fist in June
3 High-Yield Dividend Stocks to Buy Hand Over Fist in June
The Motley Fool

Rate cuts appear to be off the table for now due to surging inflation and a relatively strong jobs market. The current dynamics could drive increased market volatility, but they could also make dependable income more appealing to investors. The…

Receive a Daily briefing on Pharma Industry News

Get Started